In a significant boost to Nigeria’s healthcare reputation on the global stage, the National Agency for Food and Drug Administration and Control (NAFDAC) has successfully retained the World Health Organisation’s Maturity Level 3 (ML3) status for the regulation of medicines and vaccines. President Bola Tinubu has congratulated the agency, praising its consistent commitment to safeguarding public health.
A Major Milestone in Global Health Standards
NAFDAC first achieved the ML3 rating in 2022, becoming the first regulatory agency in Africa (among non-producing countries) to reach this level of recognition. ML3 is a designation by the WHO that confirms a country’s regulatory system functions effectively, with strong frameworks in place to ensure the safety, quality, and efficacy of medical products.
To maintain this high standard, WHO conducts periodic reviews. The most recent re-benchmarking took place between May 28 and May 30, 2025, following earlier institutional reviews and progress meetings. The WHO’s conclusion? NAFDAC has not only maintained its status but continues to operate with professionalism and efficiency as a stable, integrated regulatory authority.
Presidential Commendation
President Tinubu welcomed the WHO’s confirmation, noting that the achievement reflects the Nigerian government’s investment in strengthening its health regulatory systems. He applauded the dedication and consistency of NAFDAC’s management and staff, highlighting that their work plays a key role in enhancing Nigeria’s credibility as a global partner in health security and pandemic preparedness.
“This milestone aligns perfectly with our Renewed Hope Agenda to transform Nigeria’s healthcare landscape,” the President said.
A Broader Vision for Healthcare
The President also took the opportunity to share progress on several ongoing health reforms:
- Upgrading over 17,000 primary health centres nationwide
- Expanding access to maternal care and diagnostics in underserved areas
- Training 120,000 frontline health workers
- Doubling national health insurance coverage within three years
He reaffirmed his administration’s commitment to boosting local pharmaceutical production and attracting investment in health-related industries. “Promoting local manufacturing capacity is not just a goal – it’s a necessity,” he stressed.
Eyes on the Next Level
Looking ahead, President Tinubu pledged continued support for NAFDAC as it strives to reach WHO Maturity Level 4 (ML4) – the highest possible ranking and a gold standard in global regulatory excellence.
With this renewed recognition from WHO, Nigeria not only celebrates a regulatory win but also steps further into its role as a leader in Africa’s health future.

